Metastatic Castration-Resistant Prostate Cancer (mCRPC) trials recruiting in Colorado
All Metastatic Castration-Resistant Prostate Cancer (mCRPC) trials nationally
7
Recruiting in Colorado
6
Cities with sites
Cities in Colorado
Aurora 3Denver 2Lakewood 2Highlands Ranch 1Littleton 1Lone Tree 1
Recruiting trials in Colorado
- A Study of NX-1607 in Adults With Advanced Malignancies
- A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
- AB-3028, a Programmable Circuit T Cell Therapy in Patients With Castration Resistant Prostate Cancer (CRPC)
- Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T
- Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer